1. Home
  2. SSM vs CLDI Comparison

SSM vs CLDI Comparison

Compare SSM & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono Group N.V. Ordinary Shares

SSM

Sono Group N.V. Ordinary Shares

N/A

Current Price

$0.73

Market Cap

1.5M

Sector

N/A

ML Signal

N/A

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

N/A

Current Price

$0.55

Market Cap

1.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSM
CLDI
Founded
2016
2014
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5M
1.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SSM
CLDI
Price
$0.73
$0.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 64.6K
32.2K
Earning Date
11-10-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $45,000.00
Revenue This Year
$1,418,080.40
N/A
Revenue Next Year
$48.46
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.65
$0.09
52 Week High
$10.54
$3.10

Technical Indicators

Market Signals
Indicator
SSM
CLDI
Relative Strength Index (RSI) 31.53 29.63
Support Level N/A $0.37
Resistance Level $4.35 $0.60
Average True Range (ATR) 0.11 0.07
MACD 0.01 0.00
Stochastic Oscillator 18.90 7.08

Price Performance

Historical Comparison
SSM
CLDI

About SSM Sono Group N.V. Ordinary Shares

Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and services include Complete Solar Solutions, Solar Charge Controllers, Solar Modules, Data Services, and Engineering Services. The company's single business segment manages the financing, research and development, and product commercialization.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.

Share on Social Networks: